- Home
- PDT vs SIGA Comparison
PDT vs SIGA Comparison
Compare PDT & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDT
- SIGA
- Stock Information
- Founded
- PDT 1989
- SIGA 1995
- Country
- PDT United States
- SIGA United States
- Employees
- PDT N/A
- SIGA N/A
- Industry
- PDT Finance Companies
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- PDT Finance
- SIGA Health Care
- Exchange
- PDT Nasdaq
- SIGA Nasdaq
- Market Cap
- PDT 648.3M
- SIGA 551.0M
- IPO Year
- PDT N/A
- SIGA 1997
- Fundamental
- Price
- PDT $12.69
- SIGA $5.94
- Analyst Decision
- PDT
- SIGA
- Analyst Count
- PDT 0
- SIGA 0
- Target Price
- PDT N/A
- SIGA N/A
- AVG Volume (30 Days)
- PDT 145.6K
- SIGA 518.3K
- Earning Date
- PDT 01-01-0001
- SIGA 11-07-2024
- Dividend Yield
- PDT 8.88%
- SIGA 10.10%
- EPS Growth
- PDT N/A
- SIGA N/A
- EPS
- PDT N/A
- SIGA 1.20
- Revenue
- PDT N/A
- SIGA $173,731,386.00
- Revenue This Year
- PDT N/A
- SIGA $16.98
- Revenue Next Year
- PDT N/A
- SIGA $16.49
- P/E Ratio
- PDT N/A
- SIGA $4.97
- Revenue Growth
- PDT N/A
- SIGA 399.31
- 52 Week Low
- PDT $8.77
- SIGA $4.26
- 52 Week High
- PDT $13.05
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- PDT 40.22
- SIGA 30.77
- Support Level
- PDT $12.70
- SIGA $6.90
- Resistance Level
- PDT $13.24
- SIGA $7.89
- Average True Range (ATR)
- PDT 0.23
- SIGA 0.50
- MACD
- PDT -0.02
- SIGA -0.10
- Stochastic Oscillator
- PDT 16.67
- SIGA 1.46
About PDT John Hancock Premium Dividend Fund
John Hancock Premium Div Fund II is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest growth of capital. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, and short-term investments.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.